Filter
2579
Filtered Results: 2579
Text search:
Surveillance
and
Epidemiology
Featured
Recommendations
258
New Publications
601
Language
Document type
No document type
1261
Studies & Reports
491
Guidelines
438
Strategic & Response Plan
142
Manuals
128
Fact sheets
42
Situation Updates
39
Training Material
24
Resource Platforms
6
Infographics
6
Brochures
1
App
1
Countries / Regions
Global
127
India
81
Latin America and the Carribbean
69
Western and Central Europe
67
Liberia
62
Africa
58
Sierra Leone
49
Nigeria
47
Ethiopia
47
Kenya
45
South Africa
45
Nepal
41
Uganda
34
Bangladesh
33
Philippines
31
Eastern Europe
31
Zambia
31
Ukraine
29
Brazil
28
Malawi
26
Guinea
25
Asia
24
Tanzania
24
Rwanda
23
Ghana
22
South–East Asia Region
22
Russia
22
Mozambique
20
Congo, Democratic Republic of
20
Germany
19
Myanmar / Burma
17
Zimbabwe
16
Senegal
15
Haiti
15
Syria
14
Namibia
14
Middle East and North Africa
13
Indonesia
13
Cameroon
12
West and Central Africa
12
East and Southern Africa
12
Pakistan
12
Eastern Europe and Central Asia
11
Burkina Faso
10
Venezuela
10
Tajikistan
9
Western Pacific Region
9
Botswana
9
Colombia
8
Lesotho
8
Albania
8
Paraguay
8
USA
7
Cambodia
7
North America
7
Argentina
7
Yemen
7
Mali
7
Angola
7
South Sudan
7
Thailand
6
Afghanistan
6
Peru
6
Vietnam
6
Chile
5
Niger
5
Côte d’Ivoire / Ivory Coast
5
Moldova
5
Chad
5
Madagascar
5
North Macedonia
4
France
4
Bolivia
4
Lebanon
4
Ecuador
4
China
3
Iran
3
Jordan
3
Saudi Arabia
3
Tunisia
3
Spain
3
Sri Lanka
3
Sudan
3
Iraq
3
Somalia
3
Eswatini/ Swaziland
3
Mexico
2
El Salvador
2
Turkey
2
Benin
2
Gambia
2
Togo
2
Kazakhstan
2
Laos
2
Kyrgyzstan
2
Morocco
2
Qatar
2
Mauritania
2
Armenia
2
Belarus
2
Bosnia and Herzegovina
2
Egypt
2
Central African Republic
2
Honduras
2
Libya
2
Timor Leste/ East Timor
1
Estonia
1
Congo-Brazzaville
1
Uzbekistan
1
Burundi
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Japan
1
Denmark
1
Maldives
1
Portugal
1
Israel
1
Southern Africa
1
Papua New Guinea
1
Nicaragua
1
Greece
1
Georgia
1
Bhutan
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
846
Clinical Guidelines
248
Public Health
153
Key Resources
115
Women & Child Health
64
Pharmacy & Technologies
38
Capacity Building
23
Toolboxes
COVID-19
291
TB
252
HIV
214
Rapid Response
198
NTDs
166
AMR
156
Ebola & Marburg
112
Planetary Health
84
Mental Health
82
Malaria
61
NCDs
52
Zika
45
Cholera
38
Polio
35
Pharmacy
32
Global Health Education
32
Caregiver
26
Refugee
23
Conflict
23
Natural Hazards
20
Disability
16
Health Financing Toolbox
13
Specific Hazards
11
Social Ethics
1
Typhoon
1
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
n October 2019, WHO convened the first meeting of the Buruli ulcer laboratory network (BU-LABNET) in Yaoundé, Cameroon, bringing together 11 laboratories from nine countries at the Pasteur Centre of Cameroon (CPC), the network’s Coordinating Centre. The network was formally established at th...
Since the launch of the 2012–2020 World Health Organization (WHO) road map for the control, elim-ination and eradication of neglected tropical diseases (NTDs) (1), considerable progress against NTDs has been made. Between 2010 and 2020, the number of people requiring interventions against NTDs glo...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca...
Immunization in the context of COVID-19 pandemic
recommended
Immunizations are an essential health service that protect susceptible individuals from vaccine-preventable diseases (VPD).2 By providing timely immunizations, individuals and communities remain protected and the likelihood of a VPD outbreak decreases
This publication is available in Arabic, Chines...
The global increase of healthcare-associated infections (HAI) presents a growing concern in healthcare worldwide. According to the European Centre for Disease Prevention and Control (ECDC), the annual number of HAI exceeds 2.6million and produces the highest estimated amou...
Confronted with the important issue of patient safety, in 2002 the Fifty-fifth World Health Assembly adopted a resolution urging countries to pay the closest possible attention to the problem and to strengthen safety and monitoring systems. In May 2004, the Fifty-seventh World Health Assembly approv...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
The Global Burden of Disease (GBD) study, a collaborative endeavour of the World
Health Organization (WHO), the World Bank and the Harvard School of Public Health,
drew the attention of the international health community to the burden of neurological
disorders and many other chronic conditions. T...
2nd edition.
Like the original, this second edition of the guidance aims to inform the revision of existing national guidelines and standards for managing Tuberculosis (TB), many of which include guidance on children. It includes recommendations, based on the best available evidence, for improving ...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
Kenya Essential Medicines List 2019
recommended
The Kenya Essential Medicines List 2019 is an indispensable guide to the medicines recommended for the management of common conditions in Kenya. It is primarily directed at health care providers and medicines supply managers in the public and non-public health sectors. It should be used together wit...
2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and monitoring and...
Orientations provisoires, 2 février 2021
e document est une mise à jour des orientations provisoires de l’Organisation mondiale de la Santé (OMS) intitulées Coronavirus disease (COVID-19) outbreak: rights, roles and responsibilities of health workers, including key considerations...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu...
Bioethics 519 (online) doi:10.1111/bioe.12145 Volume 29 Number 8 2015 pp. 488–596;
Pandemic plans recommend phases of response to an emergent infectious disease (EID) outbreak, and are primarily aimed at preventing and mitigating human-to-human transmission. These plans carry presumptive weight ...
